We invest in an agnostic manner in early-stage startups.

We invest in strongly performing businesses.

We invest in Series A rounds from companies based in the countries where the bank has activity (Spain, Portugal, Ireland..).

We invest in early stages startups, with a MVP, no matter what location they are. 1.- Companies with disruptive business and/or technology-based models. 2.- Value and innovation to the consumer market preferably 3.- Active participation: structure and guidance for the improvement of strategic, operational, and leadership processes. 4.- Expansion, responsibility, and social impact

We invest in European deep tech and enterprise software companies

We invest in businesses providing commercial property services and supporting franchise growth.

We invest in software and digital products. We like to be an only investor in seed rounds from 300k EUR to 600k EUR

We invest in healthcare ventures.

We invest in infrastructure software companies across Cybersecurity, Data/AI/ML, Quantum Computing, and Climate Tech with a Series A - C sweet spot.

We invest in public and private debt and equity securities.

We invest in great Israeli entrepreneurs to build large, meaningful companies. Aleph leads Seed and A rounds in a wide gamut of companies, from b2c edtech like JoyTunes, b2c insurtech like Lemonade, b2b supply-chain like Fabric or b2g like Windward.

We invest in early-stage businesses with innovative ideas.

We invest in pre-seed and seed stage climate tech companies. Operating at the intersection of climate, technology, and inclusion we provide catalytic capital to to next-generation founders building scalable climate solutions to enable a just transition.

We invest in early-stage startups with pre-seed funding.

We invest in opportunities requiring venture capital, private debt, and lending solutions.

We invest in companies globally, focusing on their development and financing.

We invest in growth-stage companies in the technology and healthcare industries.

We invest in early-stage Indian startups.

We invest in startups at the intersection of biotech and data science through an accelerator program.

We invest in asset management.